lung cancer

67 projects

HEIndividual fellowship2027–2029Austria

SelenoResist · Targeting selenocysteine metabolism as a novel vulnerability in refractory non-small-cell lung cancer

HEIndividual fellowship2027–2030Spain

Photo-bioMOF · Designing Programmable MOF-nanocomposites for Synergistic, Redox-Driven Antitumor Therapies

3 partners · 2 countries

HEIndividual fellowship2027–2029Germany

RIPAIR · A possible new role of type I interferon (IFN)-mediated survival of influenza A virus (IAV)-infected lung cells in lung repair

HEStaff exchange2026–2029Netherlands

LIGHTHER · First-in-kind anticancer therapy combining light-controllable cytotoxic peptides and dendritic cell-based immunotherapy

6 partners · 3 countries

HEStaff exchange2026–2029Spain

TUMORGPLAT · Making patient-derived tumor organoids a reliable cancer therapy testing platform

6 partners · 3 countries

HEIndividual fellowship2026–2030Italy

RESPIRE · Artificial intelligence enabled electrospinning approach to fight pulmonary cancer

4 partners · 2 countries

HEDoctoral network2025–2029Sweden

MIPrecise · Robust biomarker binders, probes and assays for sustainable precision medicine

13 partners · 8 countries

HEStaff exchange2025–2028Serbia

EXPAND-EV · EXPANDing the value of Extracellular Vesicles as carriers of biomarker and therapy in precision healthcare

13 partners · 6 countries

HEIndividual fellowship2025–2027Belgium

noCOLDmore · Reprogramming eNdOthelial cells in immune-COLD tuMORs

2 partners · 2 countries

H2020Individual fellowship2022–2024Spain

SENOXIA · Hypoxic regulation of senescent cells secretome in lung cancer and Alzheimer's disease

H2020Individual fellowship2022–2026Czechia

MetaCross · Nucleotide metabolism crosstalk in cancer: A single cell approach

H2020Individual fellowship2021–2023United Kingdom

MSPrad · Algorithmic development of proton radiography for image-guided proton radiotherapy of lung cancer.

H2020Individual fellowship2021–2023Belgium

ECONOMY · Endothelial Cells - an Overlooked Non-hematopoietic cOmponent of tuMor immunitY

H2020Individual fellowship2021–2023Türkiye

MiTuMi · Bioengineered Matrices Mimicking the Lung Tumor Microenvironment

H2020Individual fellowship2021–2023United Kingdom

TxImmuneOrganoids · Divide and conquer: using patient-derived tumour organoids to dissect intra-tumour immune heterogeneity of non-small cell lung cancer

H2020Individual fellowship2021–2023Spain

MI-SCAN · A rapid non-invasive on-chip miRNA-based Sputum Assay for early stage Lung Cancer Screening

H2020Individual fellowship2020–2022United Kingdom

SALMYB · MYB rearrangements in Adenoid Cystic Carcinoma: protagonists or secondary characters?

H2020Individual fellowship2020–2022Netherlands

BESG · Bioengineered exosomes based approaches for the effective treatment of non-small cell lung cancer

H2020Individual fellowship2020–2022Belgium

TESTIMONY · Tumor Endothelial Cells: Gatekeepers Of Anti-Tumor Immunity

H2020Individual fellowship2019–2021Spain

Genetic Vaccine · Study the therapeutic and preventive potential of targeting oncogenic mutations with CRISPR-Cas9 technology

H2020Individual fellowship2019–2021United Kingdom

ISAC · International Study on Age-related disparity in Cancer patient survival

3 partners · 2 countries

H2020Individual fellowship2019–2021United Kingdom

TargetDUBs · Targeting ubiquitin processing in cancer and fibrosis: novel probes for the Ubiquitin Carboxy-Terminal Hydrolases

H2020Individual fellowship2019–2021Denmark

ARGONAUT · from the synthesis of gAnglioside tumouR antiGens to a platfOrm for caNcer Active immUnoTherapy

H2020Individual fellowship2019–2021United Kingdom

TRACERxTME · Constructing an evolutionary atlas of the immune landscape in lung cancer